The 36-month beta value for EHAB is also noteworthy at 1.39. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for EHAB is 43.89M, and at present, short sellers hold a 3.12% of that float. The average trading volume of EHAB on June 13, 2025 was 379.14K shares.
EHAB) stock’s latest price update
Enhabit Inc (NYSE: EHAB)’s stock price has decreased by -2.73 compared to its previous closing price of 10.25. However, the company has seen a -7.34% decrease in its stock price over the last five trading sessions. businesswire.com reported 2025-05-20 that DALLAS–(BUSINESS WIRE)–Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. Enhabit’s President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, June 10, at 10 a.m. EDT. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit Home Health & Hospice En.
EHAB’s Market Performance
EHAB’s stock has fallen by -7.34% in the past week, with a monthly drop of -4.78% and a quarterly rise of 17.16%. The volatility ratio for the week is 2.01% while the volatility levels for the last 30 days are 1.65% for Enhabit Inc The simple moving average for the past 20 days is -5.01% for EHAB’s stock, with a 20.22% simple moving average for the past 200 days.
Analysts’ Opinion of EHAB
Many brokerage firms have already submitted their reports for EHAB stocks, with Jefferies repeating the rating for EHAB by listing it as a “Buy.” The predicted price for EHAB in the upcoming period, according to Jefferies is $9.50 based on the research report published on December 09, 2024 of the previous year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see EHAB reach a price target of $8.50. The rating they have provided for EHAB stocks is “Market Perform” according to the report published on May 14th, 2024.
Jefferies gave a rating of “Hold” to EHAB, setting the target price at $8.75 in the report published on May 09th of the previous year.
EHAB Trading at 8.68% from the 50-Day Moving Average
After a stumble in the market that brought EHAB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.57% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EHAB starting from McQuiddy Collin, who sale 1,096 shares at the price of $8.58 back on Mar 10 ’25. After this action, McQuiddy Collin now owns 0 shares of Enhabit Inc, valued at $9,404 using the latest closing price.
Bolton Jeffrey, the Director of Enhabit Inc, purchase 4,000 shares at $8.69 during a trade that took place back on Dec 12 ’24, which means that Bolton Jeffrey is holding 98,144 shares at $34,760 based on the most recent closing price.
Stock Fundamentals for EHAB
Current profitability levels for the company are sitting at:
- -0.11 for the present operating margin
- 0.47 for the gross margin
The net margin for Enhabit Inc stands at -0.13. The total capital return value is set at -7.38. Equity return is now at value -22.81, with -10.34 for asset returns.
Based on Enhabit Inc (EHAB), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 518.0. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -2.72.
Currently, EBITDA for the company is -83.6 million with net debt to EBITDA at -0.0. When we switch over and look at the enterprise to sales, we see a ratio of 0.49. The receivables turnover for the company is 469.23for trailing twelve months and the total asset turnover is 62.95. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.49.
Conclusion
In summary, Enhabit Inc (EHAB) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
